General Information of Drug (ID: DM2UJM8)

Drug Name
CCP Drug Info
Synonyms
N-Pentadecylcyclohexanecarboxamide; CHEMBL190662; Cyclohexanecarboxylic acid pentadecylamide; GTPL5161; MolPort-009-019-076; VMFXYTSKMWPHQH-UHFFFAOYSA-N; N-Pentadecyl-cyclohexanecarboxamide; HMS3650I19; BDBM50171299; 1921AH; ZINC38140992; AKOS027276373; RT-014383; SR-01000946796
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
44398718
TTD Drug ID
DM2UJM8

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
S-OOPP DMH6JI8 Discovery agent N.A. Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
N-acylethanolamine-hydrolyzing acidamidase (NAAA) TTMN4HY NAAA_HUMAN Inhibitor [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5161).
2 N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase. Biochem J. 2004Apr 1;379(Pt 1):99-106.
3 Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20966-71.